{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:06:38Z","timestamp":1789247198849,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tice.2026.103632","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:15:56Z","timestamp":1779380156000},"page":"103632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Predictive value of an ICD-associated DAMP gene signature for survival and immunotherapy response in osteosarcoma patients"],"prefix":"10.1016","volume":"103","author":[{"given":"Hao","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haopeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.103632_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijc.24320","article-title":"International osteosarcoma incidence patterns in children and adolescents, middle ages, and elderly persons","volume":"125","author":"Mirabello","year":"2009","journal-title":"Int. J. Cancer J. Int. Cancer"},{"key":"10.1016\/j.tice.2026.103632_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4419-0284-9_1","article-title":"The epidemiology of osteosarcoma","volume":"152","author":"Ottaviani","year":"2009","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.tice.2026.103632_bib3","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2003.08.132","article-title":"Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols","volume":"21","author":"Kager","year":"2003","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.tice.2026.103632_bib4","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.3390\/ijms21196985","article-title":"Bone microenvironment and osteosarcoma metastasis","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103632_bib5","doi-asserted-by":"crossref","DOI":"10.1259\/dmfr.20190202","article-title":"Head and neck osteosarcoma: CT and MR imaging features","volume":"49","author":"Luo","year":"2020","journal-title":"Dentomaxillofacial Radio."},{"key":"10.1016\/j.tice.2026.103632_bib6","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","article-title":"Osteosarcoma: current treatment and a collaborative pathway to success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tice.2026.103632_bib7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"20","author":"Bielack","year":"2002","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.tice.2026.103632_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1200\/JCO.2017.75.1743","article-title":"Osteosarcoma, Chondrosarcoma, and Chordoma","volume":"36","author":"Whelan","year":"2018","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.tice.2026.103632_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpedsurg.2005.10.024","volume":"41","author":"Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma","year":"2006","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.tice.2026.103632_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tice.2026.103632_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.974087","article-title":"The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy","volume":"13","author":"Botticelli","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.103632_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms Controlling PD-L1 Expression in Cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tice.2026.103632_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tice.2026.103632_bib14","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tice.2026.103632_bib15","article-title":"Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.tice.2026.103632_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tice.2026.103632_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12885-020-06964-5","article-title":"Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells","volume":"20","author":"Solari","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tice.2026.103632_bib18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/imr.13301","article-title":"Decoding immunogenic cell death from a dendritic cell perspective","volume":"321","author":"Janssens","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tice.2026.103632_bib19","article-title":"Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tice.2026.103632_bib20","volume":"86","author":"Damage-associated molecular patterns in tumor radiotherapy","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tice.2026.103632_bib21","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41598-024-52353-4","article-title":"Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer","volume":"14","author":"Zhu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2026.103632_bib22","doi-asserted-by":"crossref","unstructured":"Sprooten, J. et al. Trial watch: chemotherapy-induced immunogenic cell death in oncology. Oncoimmunology 12, 2219591.(n.d.).","DOI":"10.1080\/2162402X.2023.2219591"},{"key":"10.1016\/j.tice.2026.103632_bib23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3389\/fimmu.2015.00588","article-title":"Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death","volume":"6","author":"Garg","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.103632_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2018.08.028","article-title":"Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies","volume":"438","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tice.2026.103632_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-025-02516-2","article-title":"Targeting OxLDL-mediated CD36\u2009+\u2009CAF reprogramming potentiates PD-1 immunotherapy in osteosarcoma","volume":"25","author":"Zeng","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tice.2026.103632_bib26","article-title":"Coupling Mitochondrial Homeostasis to Oxi-Inflamm-Aging Network Disruption via Peptide-Functionalized Nanocomposite Hydrogel for Osteoarthritis Intervention","volume":"38","author":"Zhang","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.tice.2026.103632_bib27","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1078-0432.CCR-10-2047","article-title":"Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents","volume":"17","author":"Buddingh","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tice.2026.103632_bib28","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tice.2026.103632_bib29","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.tice.2026.103632_bib30","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tice.2026.103632_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687975","article-title":"IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures","volume":"12","author":"Zeng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.103632_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief. Bioinform"},{"key":"10.1016\/j.tice.2026.103632_bib33","article-title":"Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tice.2026.103632_bib34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12931-023-02443-0","article-title":"An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma","volume":"24","author":"Wu","year":"2023","journal-title":"Respir. Res."},{"key":"10.1016\/j.tice.2026.103632_bib35","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.tice.2026.103632_bib36","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.clinthera.2016.02.028","article-title":"Cancer, and Tissue Repair","volume":"38","author":"Key Role of DAMP in Inflammation","year":"2016","journal-title":"Clin. Ther."},{"key":"10.1016\/j.tice.2026.103632_bib37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.gendis.2018.05.003","article-title":"Immunogenic effects of chemotherapy-induced tumor cell death","volume":"5","author":"Wang","year":"2018","journal-title":"Genes Dis."},{"key":"10.1016\/j.tice.2026.103632_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.780264","article-title":"Osteosarcoma and metastasis","volume":"11","author":"Sheng","year":"2021","journal-title":"Front. Oncol."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626003253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626003253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:18:52Z","timestamp":1789244332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626003253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"alternative-id":["S0040816626003253"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103632","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive value of an ICD-associated DAMP gene signature for survival and immunotherapy response in osteosarcoma patients","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103632"}}